Medical News Today -
17 Nov 2013 10:00
A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research was presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio.Psoriasis is a chronic autoimmune skin disorder that significantly impacts a patient's quality of ...
Share this Article